People with certain primary immunodeficiencies (PIDs) are at higher risk for mycobacterial infections. One type of PID that specifically increases risk is called Mendelian susceptibility to mycobacterial disease (MSMD). MSMD involves defects in the IL-12/IFN-γ pathway that are important for controlling mycobacterial infections. The most common forms of MSMD involve mutations affecting IFN-γ receptor 1 (IFNGR1), IFNGR2, IL-12p40, or IL-12Rβ1. Acquired IFN-γ deficiency from neutralizing autoantibodies can also increase risk for mycobacterial infections. Defects in innate immunity components like
The main treatment for pneumonia is antibiotics, along with rest and drinking plenty of water. If you have chest pain, you can take pain killers such as paracetamol. Treatment depends on how severe your pneumonia is. Treatment with antibiotics should be started as soon as possible after diagnosis.
Pediatric Home Service Medical Director, Dr. Roy Maynard discusses deficiencies of innate immune system and other well-defined immunodeficiency syndromes.
The main treatment for pneumonia is antibiotics, along with rest and drinking plenty of water. If you have chest pain, you can take pain killers such as paracetamol. Treatment depends on how severe your pneumonia is. Treatment with antibiotics should be started as soon as possible after diagnosis.
Pediatric Home Service Medical Director, Dr. Roy Maynard discusses deficiencies of innate immune system and other well-defined immunodeficiency syndromes.
Goals of this presentation:
1.Prevent morbidity and mortality due to the failure to recognize Primary Immunodeficiency
2. Decrease your risk of having to answer the question: “Why did you miss this?”
3. Review the safe and effective use of gamma globulin
Presentation by:
Richard L. Wasserman, M.D.,Ph.D.
Clinical Professor of Pediatrics
University of Texas Southwestern Medical School
This presentation is an overview of primary and secondary immunodeficiency disorders with highlights on the genetic basis of primary disorders and associated factors underlying secondary disorders, as well a management of these disorders
Goals of this presentation:
1.Prevent morbidity and mortality due to the failure to recognize Primary Immunodeficiency
2. Decrease your risk of having to answer the question: “Why did you miss this?”
3. Review the safe and effective use of gamma globulin
Presentation by:
Richard L. Wasserman, M.D.,Ph.D.
Clinical Professor of Pediatrics
University of Texas Southwestern Medical School
This presentation is an overview of primary and secondary immunodeficiency disorders with highlights on the genetic basis of primary disorders and associated factors underlying secondary disorders, as well a management of these disorders
Immunological Disorders can be classified into 3 distinct categories.They are Hypersensitivity, Autoimmunity and Immunodeficiency.Here in this presentation we talk about Immunodeficiency disorders.Get more on our blog : http://dentistryandmedicine.blogspot.com/
Controversy: the role of immunomodulator in allergic caseSuharti Wairagya
dipresentasikan oleh Erwanto BW Teguh HK
Divisi Alergi Imunologi Klinik Departemen 1. Penyakit Dalam FKUI/RSCM Bagian Penyakit Dalam SMF non Bedah RS. dr. H. Marzoeki Mahdi Bogor
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
6. MSMD
Many types of PID predispose to mycobacterial
infection
One type that specific for mycobacterial infection is
“ MSMD”
“Medelian susceptibility to mycobacterial diseases”
Defect in IL-12/23-IFN-γ circuit
Compose of 6 syndromes
15. IFNγR1 deficiency
Complete IFNγR1 deficiency
- loss of expression of receptor at cell surface
- BCG infection and environmental mycobacteria
- majority of patients death before 3 yrs old
- other infection => non-typhoidal salmonella ,Listeria, some
viral infection ( rare, individual pts.)
- pathology => multibacillary,poorly organized granuloma
- prognosis is poor
- Therapeutic option is BMT
16. Partial IFNγR1 deficiency
- Mixed of wild-type and mutant type in cell surface
- impair recycling of impaired receptor
- less severe disease and curable with prolong antibiotic
- BCG and NTM infection, non typhoidal infection
- can control dis with IFNγ Rx
- several patients had clinical liked histiocytosis X
23. IFNγR2 deficiency
Complete deficiency
- signal transducing chain of the IFNγ receptor
- tightly regulate than IFNγR1 chain
- accumulation of abnormal protein in cytoplasm
- clinical phenotype severe as in IFNγR1 ( splenomegaly)
Partial deficiency
- missense mutation
- impaired response to IFNγ
- molecular mechanism is unclear
25. IL12p40 deficiency
- homozygous frameshift mutation
- Mortality 38 %
- cause of infection same as other phenotype
- severe than IL-12 Rβ1 deficiency
- higher incidence of Salmonella infection
- can correct defect with rec.IL-12
- good prognosis
- treatment with antimicrobial and recombinant IFN-γ
Also defect in IL23/17 circuit !
30. IL12Rβ1 deficiency
- most common in MSMD
- loss of surface expression of IL12Rβ1 on activated T cell
- complete absence response to IL12/23
- milder clinical phenotype than IFNγ dependent
- IL-12 independent pathway
- 45% develop infection to mycobacterium and salmonella
- mortality 11% ,good prognosis ( J Exp Med 2003;197:527-35)
- Rx antmicrobial agent and rec.IFN-γ as need
TyK2 deficiency ?
35. Stat 1 deficiency
- Stat 1 is required for both type I/II IFN
- in pathway of type II IFN the product is GAF
- clinical phenotype less severe than other type
- good prognosis
- not require HSCT
37. NEMO defects
- NEMO is critical and non redundant component of
NF-кB
- itself no catalytic activity
- hypomorphic mutation
- X link recessive disease
- EDA-ID susceptibility to many type of infection
- recently, NEMO mutation susceptibility to
mycobacterial infection without EDA-ID
38.
39.
40.
41.
42.
43. Acquired IFN-γ Deficiency
Case report in world-wild
Neutralizing Auto-antibodies to IFN-γ
Demonstrate Auto-antibodies in serum
The patients experienced disseminated
tuberculosis as well as NTM infections
55. Abul K. Abbas et al.,Cellular and Molecular Immunology,6th ed,2007
56. In animal model
- TLR 2/4/9 KO mice enhance mortality
(A Bafica et al. J.Exp Med 202 ; 1715-24)
(J.M.Blander et al. Science 304 1014-18)
(R.M Yates et al. Immunity 23 409-17)
- TLR 2/4/9 deficient mice keep infection of
mycobacterium similar as wild type
Role of TLRs in innate and adaptive
response to MycobacteriumJ is still28;2008:680-94)
(Hoelscher et al. Eur Immuno
controversial !
57. MyD 88
Adaptor molecule
Also liking receptor for IL-1β and IL-18
IL-1β => protective role in TB
In animal model MyD 88 Ko mice slightly increase
susceptibility to mycobacterium
(Hoelscher et al. Eur J Immuno 28;2008:680-94)
Some experimental result was different from
above data
( Suragawa. Microbio Immuno 47;84:2003)
58. MyD 88
Abul K. Abbas et al.,Cellular and Molecular Immunology,6th ed,2007
65. Take home message
Mycobacterial infection can occur in multiple
type of PID
MSMD “ what did you know?”
Defect in innate immunity can increase
susceptibility to mycobacterial infection
In adult mycobacterial infection may caused
by autoantibodies to IFN-γ
66. QUIZ
1. What is the most frequent type of MSMD ?
a. XR
b. AR
c. AD
d. polygenic
67. 2.Which of the following genes has not been
identified as a cause for MSMD ?
a. IFNGR2
b. stat 1
c. stat 3
d. IL-12 B
68. 3. A defect in the gene for which of the following
cytokines is associated with MSMD ?
a. IFN-γ
b. IL-12
c. IL-2
d. IL-10
69. 4.Patients with an impaired IL-12/23 pathway
have high incidence of infection with …
a. Streptococcus pneumoniae
b. Pneumocystis
c. Salmonella
d. Staphylococcus
e. Klebsella
70. 5. Which of the following mechanisms
stimulates the STAT-1 pathway infection
with mycobacteria species
a. IFN-α/β activate GAF
b. IFN-γ activate GAF
c. IFN-δ activate ISGF 3
d. IFN- γ activate ISGF 3
71. 6. Which type of Ab that neutralized IFN- γ in
Acquired IFN- γ Deficiency?
a. Ig A
b. Ig G1
c. Ig G2
d. Ig G3
e. Ig G4
72. 7.Which type of PID that not increase risk for
mycobacterial dis ?
a. HIEs
b. HIGM
c. SCID
d. Artemis deficiency
e. LAD
73. 8. What type of MSMD is X-link disease ?
a. IFNγR1 deficiency
b. IFNγR2 deficiency
c. STAT1 defect
d. NEMO defect
e. IL-12 deficiency